Insulet Corp (NAS:PODD)
$ 199.42 2.91 (1.48%) Market Cap: 13.97 Bil Enterprise Value: 14.41 Bil PE Ratio: 60.40 PB Ratio: 17.65 GF Score: 84/100

Insulet Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 01:45PM GMT
Release Date Price: $218.11 (+3.08%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Well good morning everyone and welcome to the Morgan Stanley Healthcare Conference. As we progress through the morning, I am coming to you live from San Francisco. I love saying that. I'm probably going to say it several times during the next several days. But thank you all for joining us. It's a pleasure to be moved to the morning to have with us here another medical device company, Insulet. As many or a couple of you know, we have multiple members from management with us from the company, including Shacey Petrovic, their CEO; Wayde McMillan, their CFO; as well as Bret Christensen, their EVP and COO.

You didn't know this, but Shacey has promised exciting updates throughout this presentation. We're super excited to hear some of these updates, and we'll get to it in a second. As you've heard me say, please look at the Morgan Stanley website under Research Disclosures to see interesting funs and facts about myself.

With that, Shacey, the floor is yours. I'll turn it over to you for a brief preamble and then we'll get into it.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot